Coherus Biosciences | CHRS - Market Capitalization


Coherus Biosciences reported $153.3M in Market Capitalization this August of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 435.86B 8.73B Aug/2026
Acadia Pharmaceuticals USD 4.53B 199M Aug/2026
Akebia Therapeutics USD 427M 297M Dec/2025
ALKERMES USD 7.93B 806M Aug/2026
Alnylam Pharmaceuticals USD 40.19B 3.96B Jun/2026
Amarin USD 290M 51M Dec/2025
Amgen USD 209.65B 14.21B Aug/2026
Baxter International USD 11.01B 2.34B Jun/2026
Biogen USD 31.9B 5B Jun/2026
BioMarin Pharmaceutical USD 11.71B 651M Aug/2026
Bristol-Myers Squibb USD 117.66B 6.17B Jun/2026
Coherus Biosciences USD 172M 19M Dec/2025
Eli Lilly USD 1.11T 18.32B Aug/2026
Fujifilm JPY 3.69T 340.04B Mar/2026
Gilead Sciences USD 168.68B 11.82B Aug/2026
Merck USD 324.18B 6.81B Aug/2026
Pacira USD 1.28B 286M Aug/2026
Perrigo USD 1.45B 135M Aug/2026
Pfizer USD 153.17B 14.73B Aug/2026
Regeneron Pharmaceuticals USD 65.37B 16.31B Jun/2026
Sarepta Therapeutics USD 1.5B 402M Aug/2026
Teva Pharmaceutical Industries USD 114.54B 80.27B Jun/2026
Vertex Pharmaceuticals USD 137.33B 11.26B Aug/2026
Xencor USD 1.21B 19M Aug/2026
Zoetis USD 35.38B 5.25B Aug/2026